Mounjaro and lean mass: how much muscle is actually lost?

By Douglas AraújoUpdated 3 min read

Exercise professional · creator of the Letz method

Short answer

Semaglutide and tirzepatide produced average weight losses of about 15% to over 20% of body weight in 68 to 72 weeks in the cited trials. Part was lean mass, which is not solely muscle. Adequate protein and resistance training are supportive measures, adjusted to clinical condition and tolerance.

What the trials measured

In the cited trials, semaglutide and tirzepatide produced average weight losses of about 15% to over 20% of body weight in 68 to 72 weeks. Total body weight was the primary outcome; secondary analyses and reviews help clarify the composition of this loss.

Part of the weight lost was lean mass. This metric includes muscle, but also water, organs, and other non-fat tissues: a reduction in lean mass is not equivalent to the exact same amount of muscle lost. The composition and rate of weight loss vary between individuals.

Why lean mass matters more than the number on the scale

Preserving muscle and functional capacity matters for strength and mobility. A lean mass measurement alone does not indicate how much strength someone has lost; performance and clinical evaluation help provide the full picture.

This carries a direct practical consequence for the next phase: reaching a target weight with less lean mass leaves a narrower margin for maintaining that weight. This is one reason why what happens after treatment warrants as much planning as the treatment itself.

The two strategies supported by the evidence

The first is protein. During a calorie deficit, protein requirements increase rather than decrease: a higher intake signals to the body to spare lean tissue. When appetite is substantially reduced, this no longer happens automatically and requires deliberate planning—protein must be prioritized within a total food volume that has become quite small.

The second is resistance training. Mechanical tension is the other signal that preserves lean tissue, and it cannot be replaced by walking or aerobic exercise. A study evaluating supervised exercise combined with liraglutide maintained weight loss more effectively and reduced body fat further than either strategy alone—the combination was superior to its individual parts.

Neither of these measures involves the medication itself. They represent the framework built around it, and that is precisely where structured support makes a difference.

What this article does not say

It does not say that you should, or should not, use the medication. It does not suggest any dose, medication switch, or discontinuation. These decisions belong to the physician managing your care, and no app has sufficient clinical information to take part in them.

It is also worth noting a limitation of the studies themselves: the trials included intensive lifestyle intervention alongside the medication. The published outcomes reflect treatment combined with support, not medication alone.

Frequently asked questions

How much of the weight lost on Mounjaro is muscle?

There is no single percentage of muscle lost. Body composition analyses measure lean mass, which also includes water and other tissues. Adequate protein and resistance training are supportive strategies, but they do not guarantee the same outcome for everyone.

Can lean mass loss be completely prevented?

There is no evidence that lean mass loss can be eliminated entirely during a calorie deficit of this magnitude. What the scientific literature supports is minimizing it through high protein intake and resistance training maintained throughout treatment.

Do I need to lift heavy or is walking enough?

Walking does not replace resistance training for preserving lean mass: the stimulus that signals the maintenance of lean tissue is mechanical and specific. Aerobic activity offers other health benefits, but it does not serve this function.

Registry rules cited here

  • GLP-1: Lean Mass and Regain After DiscontinuationTrials observed substantial weight loss, with some reduction in lean mass. In the STEP 1 extension, weight regain followed withdrawal of both semaglutide and lifestyle support. Supervised exercise was studied with liraglutide.
  • Nutritional Support During GLP-1 TreatmentMonitoring should prioritize symptoms, nutritional adequacy, protein, resistance training, and preserving lean mass and function.
  • Higher Protein Intake During a Calorie DeficitHigher protein intake and resistance training may help preserve lean mass during an energy deficit. Needs vary; the studies do not establish a universal range or guarantee muscle gain.
  • Protein and Training AdaptationSufficient protein can support gains in lean mass and strength alongside training; the response varies and does not increase indefinitely with higher intakes.

Sources cited

Informational content about training and nutrition. It is not a recommendation, prescription or adjustment of any medication, and it does not replace assessment by your doctor or dietitian.

Keep reading